Omnicell, Inc.

NasdaqGS OMCL

Omnicell, Inc. Market Capitalization on January 14, 2025: USD 1.96 B

Omnicell, Inc. Market Capitalization is USD 1.96 B on January 14, 2025, a 26.02% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Omnicell, Inc. 52-week high Market Capitalization is USD 2.45 B on October 30, 2024, which is 24.79% above the current Market Capitalization.
  • Omnicell, Inc. 52-week low Market Capitalization is USD 1.18 B on July 10, 2024, which is -40.04% below the current Market Capitalization.
  • Omnicell, Inc. average Market Capitalization for the last 52 weeks is USD 1.65 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqGS: OMCL

Omnicell, Inc.

CEO Mr. Randall A. Lipps
IPO Date Aug. 9, 2001
Location United States
Headquarters 590 East Middlefield Road
Employees 3,660
Sector Health Care
Industries
Description

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

Similar companies

EVH

Evolent Health, Inc.

USD 11.18

-9.77%

NRC

National Research Corporation

USD 16.93

-1.97%

CERT

Certara, Inc.

USD 10.74

-2.10%

DH

Definitive Healthcare Corp.

USD 3.92

-0.25%

HSTM

HealthStream, Inc.

USD 31.47

1.68%

FORA

Forian Inc.

USD 2.08

-0.48%

StockViz Staff

January 15, 2025

Any question? Send us an email